Citation:
Manolakopoulos S, Sevastianos V, Triantafyllou K, Goulis I, Cholongitas E, Oikonomopoulou M, Karaoulani T, Dalekos GN, Samonakis D, Deutsch M, et al. Sofosbuvir/Velpatasvir (SOF/VEL)+/-Ribavirin (RBV) in the Treatment of Genotype 3 (GT3) Chronic Hepatitis C (CHC) Patients. Heraclis: A Hellenic Multicenter Real-Life Cohort Clinical Study. In: Hepatology. Vol. 68. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 378A–379A. Copy at http://www.tinyurl.com/23tkv7yk